Literature DB >> 14621126

Compounding TPN admixtures: then and now.

David F Driscoll1.   

Abstract

Compounding TPN admixtures has significantly developed since the first clinical reports by Dr. Dudrick and colleagues from the University of Pennsylvania approximately 35 years ago. Today, the responsibility for the compounding of sage parenteral nutrition admixtures for patients incapable of oral or enteral nutrition primarily rests with the pharmacy department. Although others may influence the desirable components to be contained therin, no one is more qualified to deal with the physicochemical issues and aseptic technique compounding requirements than a registered pharmacist. In fact, the United States Pharmacopeia (USP) , the official drug compendium in the US since 1906, has published Chapter 797 entitled "Pharmaceutical Compounding--Sterile Preparations", enforceable by the FDA, and makes clear the role of the pharmacist in the compounding of safe parenteral admixtures. Ultimately, after careful pharmaceutical review of the final formulation, the composition of the final admixture for infusion will be determined based on the ability to safely compound the prescribed additives in the desired quantities of a specified volume of sterile fluid. There will always be instances, where, for example the patient's needs cannot be safely met through the TPN admixture, primarily because of stability, compatibility and/or sterility issues. When this occurs, suitable alternative methods of delivering the additives in question must be sought so as not to compromise the safety issues of the final TPN infusion. Although there have been many advances in the development of nutritional additives, compounding devices, and containers, significant safety issues continue to arise necessitating further modification of paretneral nutrition protocols. ASPEN, through periodic reviews of tis published guidelines, such as the 1998 Safe Practices for Parenteral Nutrition Formulations, is in a key position to keep nutrition support clinicians abreast of the central issues affecting the safety of TPN therapy.(Journal of Parenteral and Enteral Nutrition

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14621126     DOI: 10.1177/0148607103027006433

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  6 in total

1.  Assessment of implementation of a standardized parenteral formulation for early nutritional support of very preterm infants.

Authors:  Richard Lenclen; Sylvie Crauste-Manciet; Philippe Narcy; Saida Boukhouna; Amélie Geffray; Marie-Noëlle Guerrault; François Bordet; Denis Brossard
Journal:  Eur J Pediatr       Date:  2006-04-19       Impact factor: 3.183

2.  Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy.

Authors:  Neil Gupta; Susan N Hocevar; Heather A Moulton-Meissner; Kelly M Stevens; Mary G McIntyre; Bette Jensen; David T Kuhar; Judith A Noble-Wang; Rick G Schnatz; Shawn C Becker; Eric S Kastango; Nadine Shehab; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

Review 3.  Organisation, regulations, preparation and logistics of parenteral nutrition in hospitals and homes; the role of the nutrition support team - Guidelines on Parenteral Nutrition, Chapter 8.

Authors:  S C Bischoff; L Kester; R Meier; R Radziwill; D Schwab; P Thul
Journal:  Ger Med Sci       Date:  2009-11-18

Review 4.  Practical handling of AIO admixtures - Guidelines on Parenteral Nutrition, Chapter 10.

Authors:  S Mühlebach; C Franken; Z Stanga
Journal:  Ger Med Sci       Date:  2009-11-18

5.  Safety and efficacy of an olive oil-based triple-chamber bag for parenteral nutrition: a prospective, randomized, multi-center clinical trial in China.

Authors:  Zhen-Yi Jia; Jun Yang; Yang Xia; Da-Nian Tong; Gary P Zaloga; Huan-Long Qin
Journal:  Nutr J       Date:  2015-11-14       Impact factor: 3.271

6.  Molecular investigation of isolates from a multistate polymicrobial outbreak associated with contaminated total parenteral nutrition in Brazil.

Authors:  Marcelo Pillonetto; Lavinia Arend; Suzie M T Gomes; Marluce A A Oliveira; Loeci N Timm; Andreza F Martins; Afonso L Barth; Alana Mazzetti; Lena Hersemann; Theo H M Smits; Marcelo T Mira; Fabio Rezzonico
Journal:  BMC Infect Dis       Date:  2018-08-13       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.